Changes to the Corporate Structure

As described in detail in Chapter 1.2 of the Annual Report 2015, a new organizational structure was introduced effective January 1, 2016, dividing the business into five reporting segments: the Pharmaceuticals, Consumer Health and Crop Science divisions; the Animal Health business unit; and the legally and economically independent company Covestro AG, over which Bayer AG continues to exercise control.